[1]
|
Heldin, C.H., Miyazono, K. and ten Dijke, P. (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471. doi:10.1038/37284
|
[2]
|
Ducy, P. and Karsenty, G. (2000) The family of bone morphogenetic proteins. Kidney International, 57, 2207-2214. doi:10.1046/j.1523-1755.2000.00081.x
|
[3]
|
Bellusci, S., et al. (1996) Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development, 122, 1693-1702.
|
[4]
|
Frisch, A. and Wright, C.V. (1998) XBMPRII, a novel Xenopus type II receptor mediating BMP signaling in embryonic tissues. Development, 125, 431-442.
|
[5]
|
Hemmati-Brivanlou, A. and Thomsen, G.H. (1995) Ven-tral mesodermal patterning in Xenopus embryos: Expression patterns and activities of BMP-2 and BMP-4. Devepment and Genetics, 17, 78-89.
|
[6]
|
Hild, M., et al. (2000) The roles of BMPs, BMP antagonists, and the BMP signaling transducers Smad1 and Smad5 during dorsoventral patterning of the zebrafish embryo. Ernst Schering Research Foundation Workshop, 29, 81-106.
|
[7]
|
Smith, W.C. (1999) TGF beta inhibitors. New and unexpected requirements in vertebrate development. Trends in Genetics, 15, 3-5.
doi:10.1016/S0168-9525(98)01641-2
|
[8]
|
Thomsen, G.H. (1997) Antagonism within and around the organizer: BMP inhibitors in vertebrate body patterning. Trends in Genetics, 13, 209-211.
doi:10.1016/S0168-9525(97)01117-7
|
[9]
|
Wozney, J.M. (1998) The bone morphogenetic protein family: Multifunctional cellular regulators in the embryo and adult. European Journal of Oral Sciences, 1, 1- 60-166.
|
[10]
|
Iwasaki, S., et al. (1995) Distribution and characterization of specific cellular binding proteins for bone mor-phogenetic protein-2. Journal of Biological Chemistry, 270, 5476-82.
doi:10.1074/jbc.270.10.5476
|
[11]
|
Josso, N. and di Clemente, N. (1997) Serine/threonine kinase receptors and ligands. Current Opinion in Genetics and Development, 7, 371-377.
doi:10.1016/S0959-437X(97)80151-7
|
[12]
|
Kawabata, M., Imamura, T. and Miyazono, K. (1998) Signal transduction by bone morphogenetic proteins. Cytokine and Growth Factor Reviews, 9, 49-61.
doi:10.1016/S1359-6101(97)00036-1
|
[13]
|
Nohe, A., et al. (2002) The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. Journal of Biological Chemistry, 277, 5330-5338.
doi:10.1074/jbc.M102750200
|
[14]
|
Beppu, H., et al. (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Developmental Biology, 221, 249-258.
doi:10.1006/dbio.2000.9670
|
[15]
|
Kawabata, M., Chytil, A. and Moses, H.L. (1995) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. Journal of Biological Chemistry, 270, 5625-5630. doi:10.1074/jbc.270.10.5625
|
[16]
|
Nohno, T., et al. (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. Journal of Biological Chemistry, 270, 22522-22526.
doi:10.1074/jbc.270.38.22522
|
[17]
|
Cogan, J.D., et al. (2006) High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 174, 590-598.
doi:10.1164/rccm.200602-165OC
|
[18]
|
Deng, Z., et al. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. American Journal of Human Genetics, 67, 737-744.
doi:10.1086/303059
|
[19]
|
Lane, K.B., et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nature Genetics, 26, 81-84. doi:10.1038/79226
|
[20]
|
Thomson, J.R., et al. (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. Journal of Medicine Genetics, 37, 741-745. doi:10.1136/jmg.37.10.741
|
[21]
|
Humphries, D.E., et al. (1994) Structure and expression of the promoter for the human type II transforming growth factor-beta receptor. Biochemical and Biophysical Research Communications, 203, 1020-1027.
doi:10.1006/bbrc.1994.2284
|
[22]
|
Ahn, B.H., et al. (2007) Phorbol myristate acetate-induced EGR-1 expression is suppressed by phospholipase D isozymes in human glioma cells. FEBS Letters, 581, 5940-5944. doi:10.1016/j.febslet.2007.11.077
|
[23]
|
Dunnmon, P.M., et al. (1990) Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. Journal of Molecular and Cellular Cardiology, 22, 901-910.
doi:10.1016/0022-2828(90)90121-H
|
[24]
|
Maass, A., et al. (1994) Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. Biochemical and Biophysical Research Communications, 202, 1337-1346. doi:10.1006/bbrc.1994.2077
|
[25]
|
You, L. and Jakowlew, S.B. (1997) Identification of early growth response gene-1 (EGR-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display. American Journal of Respiratory and Critical Care Medicine, 17, 617-624.
|
[26]
|
Sukhatme, V.P., et al. (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell, 53, 37-43.
doi:10.1016/0092-8674(88)90485-0
|
[27]
|
Matheny, C., Day, M.L. and Milbrandt, J. (1994) The nuclear localization signal of NGFI-A is located within the zinc finger DNA binding domain. Journal of Biological Chemistry, 269, 8176-8181.
|
[28]
|
Kubosaki, A., et al. (2009) Genome-wide investigation of in vivo EGR-1 binding sites in monocytic differentiation. Genome Biology, 10, 41.
doi:10.1186/gb-2009-10-4-r41
|
[29]
|
Seyfert, V.L., et al. (1990) EGR-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation. Journal of Immunology, 145, 3647-3653.
|
[30]
|
McCaffrey, T.A., et al. (2000)High-level expression of EGR-1 and EGR-1-inducible genes in mouse and human atherosclerosis. Journal of Clinical Investigation, 105, 653-662. doi:10.1172/JCI8592
|
[31]
|
Lee, S.L., et al. (1996) Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (EGR-1). Science, 273, 1219-1221.
doi:10.1126/science.273.5279.1219
|
[32]
|
Sevetson, B.R., Svaren, J. and Milbrandt, J. (2000) A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. Journal of Biological Chemistry, 275, 9749-9757. doi:10.1074/jbc.275.13.9749
|
[33]
|
Tourtellotte, W.G., et al. (2000) Functional compensation by EGR4 in EGR1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis. Molecular and Cellular Biology, 20, 5261-5268.
doi:10.1128/MCB.20.14.5261-5268.2000
|
[34]
|
Swirnoff, A.H., et al. (1998) NAB1, a corepressor of NGFI-A (EGR-1), contains an active transcriptional repression domain. Molecular and Cellular Biology, 18, 512-524.
|
[35]
|
Svaren, J., et al. (1996) NAB2, a corepressor of NGFI-A (EGR-1) and Krox20, is induced by proliferative and differentiative stimuli. Molecular and Cellular Biology, 16, 3545-3553.
|
[36]
|
Russo, M.W., Sevetson, B.R. and Milbrandt, J. (1995) Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proceedings of the National Academy of Sciences, USA, 92, 6873-6877.
|
[37]
|
Loots, G.G. and Ovcharenko, I. (2005) Dcode.org anthology of comparative genomic tools. Nucleic Acids Research, 33, 56-64. doi:10.1093/nar/gki355
|
[38]
|
Wang, C., et al. (2005) EGR-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo. Cardiovascular Research, 65, 187-194. doi:10.1016/j.cardiores.2004.09.026
|
[39]
|
Aldred, M.A., et al. (2007) Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 176, 819-824.
doi:10.1164/rccm.200701-164OC
|
[40]
|
Wang, H., et al. (2009) Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension. European Journal of Human Genetics, 17, 1063-1069. doi:10.1038/ejhg.2009.3
|
[41]
|
Beppu, H., et al. (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Developmental Biology, 221, 249-258.
doi:10.1006/dbio.2000.9670
|
[42]
|
Svaren, J., et al. (2000) EGR1 target genes in prostate carcinoma cells identified by microarray analysis. Journal of Biological Chemistry, 275, 38524-38531.
doi:10.1074/jbc.M005220200
|
[43]
|
Abdel-Malak, N.A., et al. (2009) Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 209-216. doi:10.1161/ATVBAHA.108.181073
|
[44]
|
Lee, Y.S., et al. (2005) Adenoviral-mediated delivery of early growth response factor-1 gene increases tissue perfusion in a murine model of hindlimb ischemia. Molecular Therapy, 12, 328-336.
doi:10.1016/j.ymthe.2005.03.027
|
[45]
|
Fahmy, R.G., et al. (2003) Transcription factor EGR-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nature Medicine, 9, 1026-1032. doi:10.1038/nm905
|
[46]
|
Szabo, I.L., et al. (2001) NSAIDs inhibit the activation of Egr-1 gene in microvascular endothelial cells: A key to inhibition of angiogenesis? Journal of Physiology, Paris, 95, 379-383. doi:10.1016/S0928-4257(01)00051-1
|
[47]
|
Sweet, M.J. and Hume, D.A. (1996) Endotoxin signal transduction in macrophages. Journal of Leukocyte Biology, 60, 8-26.
|
[48]
|
Dewachter, L., et al. (2009) Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. European Respiratory Journal, 34, 1100-1110. doi:10.1183/09031936.00183008
|
[49]
|
Rondelet, B., et al. (2005) Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. American Journal of Physiology-Heart and Circulatory Physiology, 289, 2319-2324.
doi:10.1152/ajpheart.00518.2005
|
[50]
|
Pritchard, M.T. and Nagy, L.E. (2005) Ethanol-induced liver injury: Potential roles for EGR-1. Alcohol Clinical Experiment Research, 29, 146S-150S.
doi:10.1097/01.alc.0000189286.81943.51
|
[51]
|
Revest, J.M., et al. (2005) The MAPK pathway and EGR-1 mediate stress-related behavioral effects of glucocorticoids. Nature Neuroscience, 8, 664-672.
doi:10.1038/nn1441
|
[52]
|
Quinones, A., Dobberstein, K.U. and Rainov, N.G. (2003) The EGR-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. Life Science, 72, 2975-2992.
doi:10.1016/S0024-3205(03)00230-3
|
[53]
|
Yan, S.F., et al. (2000) EGR-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Medicine, 6, 1355-1361.
doi:10.1038/82168
|
[54]
|
Stula, M., et al. (2000) Influence of sustained mechanical stress on EGR-1 mRNA expression in cultured human endothelial cells. Molecular and Cellular Biochemistry, 210, 101-108. doi:10.1023/A:1007126218740
|